Onelife Capital Advisors Limited has successfully completed its postal ballot process with overwhelming shareholder approval for the re-appointment of three independent directors. The company submitted regulatory disclosures to BSE Limited and National Stock Exchange of India Limited on March 10, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Postal Ballot Results and Regulatory Compliance

All three special resolutions for the re-appointment of independent directors achieved identical approval rates of 99.82% through remote e-voting conducted via Central Depository Services (India) Limited's platform. The voting process was completed on March 07, 2026, with the scrutinizer's report submitted by Mr. Mukesh Siroya of M. Siroya & Co, Company Secretaries.

Director Appointments and Effective Dates

The re-appointments are for second five-year terms as Non-Executive Independent Directors. Dr. Ranu Jain and Mr. Nitesh Singh's appointments are effective from March 29, 2026, while Mr. Abhay Sethia's appointment is effective from January 13, 2026.

Voting Participation and Shareholder Support

The postal ballot was conducted pursuant to Section 110 of the Companies Act, 2013, with the record date set as January 30, 2026. The company had 10174 total shareholders on the record date, with 63 members participating in the voting process.

Corporate Governance and Compliance

The successful completion demonstrates strong shareholder confidence in the board's governance structure. All directors confirmed they are not related to any existing Directors or Key Managerial Personnel of the company and are not debarred from holding directorship pursuant to any SEBI order or other authority. The company maintained full compliance with all applicable regulations including the Companies Act, 2013, and SEBI listing requirements, with electronic data and relevant records preserved as per regulatory requirements.

Onelife Capital Advisors Limited has extended the closing date of its ongoing rights issue following a decision by the Right Issue Committee of the Board of Directors during its meeting held on March 02, 2026. The committee approved the extension to provide eligible shareholders with additional time to participate in the offering.

Rights Issue Timeline Extension

The rights issue, which commenced on Monday, February 23, 2026, was originally scheduled to close on Friday, March 06, 2026. Following the committee's decision, the closing date has been extended to Monday, March 16, 2026. This extension aims to provide a further window of opportunity for eligible equity shareholders to submit their applications.

Additionally, the last date for on-market renunciation has been revised from Monday, March 02, 2026, to Tuesday, March 10, 2026, giving shareholders more flexibility in their investment decisions.

Revised Schedule Details

The company has provided a comprehensive timeline showing both the original and revised dates for key events:

Terms and Conditions Unchanged

The company has clarified that there are no changes to the terms and conditions of the Letter of Offer (LOF), Abridged Letter of Offer (ALOF), or Application Form. The only modifications relate to the issue closing date and the consequent revision to the indicative timeline of post-issue activities.

Document Availability and Compliance

An addendum to the LOF containing the revised closing date and timeline will be made available on multiple platforms for stakeholder access. These documents can be found on the company's website at www.onelifecapital.in , the registrar's website at www.kfintech.com , and the stock exchange websites at www.bseindia.com and www.nseindia.com .

The Right Issue Committee meeting commenced at 1:45 PM and concluded at 2:15 PM on March 02, 2026. The company has communicated this development to both BSE Limited and National Stock Exchange of India Limited in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.